ABCB » Topics » Note 6. Stock-Based Compensation

This excerpt taken from the ABCB 10-K filed Mar 16, 2010.

Stock-Based Compensation

 

The Company accounts for its stock compensation plans using a fair value based method whereby compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period.

During 2008, the Company determined that certain stock grants would not vest and as a result reversed amounts expensed in prior years. The Company recorded approximately $701,000, ($97,000), and $444,000 of stock-based compensation cost in 2009, 2008 and 2007, respectively.

These excerpts taken from the ABCB 10-K filed Mar 16, 2009.

Stock-Based Compensation

The Company accounts for its stock compensation plans using a fair value based method whereby compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period.

During 2008, the Company determined that certain stock grants would not vest and as a result reversed amounts expensed in prior years. The Company recorded approximately ($97,000), $444,000 and $339,000 of stock-based compensation cost in 2008, 2007 and 2006, respectively. In December 2005, the Company accelerated the vesting of 7,332 options to purchase its common stock to avoid the income statement impact of adopting FASB Statement 123R in future years for those options.

Stock-Based Compensation

STYLE="margin-top:12px;margin-bottom:0px; margin-left:13%" ALIGN="justify">The Company accounts for its stock compensation plans using a fair value based method whereby compensation cost is measured at the grant
date based on the value of the award and is recognized over the service period, which is usually the vesting period.

SIZE="2">During 2008, the Company determined that certain stock grants would not vest and as a result reversed amounts expensed in prior years. The Company recorded approximately ($97,000), $444,000 and $339,000 of stock-based compensation cost in
2008, 2007 and 2006, respectively. In December 2005, the Company accelerated the vesting of 7,332 options to purchase its common stock to avoid the income statement impact of adopting FASB Statement 123R in future years for those options.

This excerpt taken from the ABCB 10-K filed Mar 16, 2006.

Stock-Based Compensation

Statement of Financial Accounting Standards (SFAS) No. 123, Accounting for Stock-Based Compensation, encourages all entities to adopt a fair value based method of accounting for employee stock compensation plans whereby compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period. However, it also allows an entity to continue to measure compensation cost for those plans using the intrinsic value based method of accounting prescribed by Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees, whereby compensation cost is the excess, if any, of the quoted market price of the stock at the grant date over the amount an employee must pay to acquire the stock. The Company has elected to continue with the accounting methodology of Opinion No. 25. No stock-based employee compensation cost is reflected in net income, as all options granted under the plans had an exercise price equal to the market value of the underlying stock on the date of grant.

The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of FASB Statement No. 123 to stock-based employee compensation.

 

     Years Ended December 31,  
     2005     2004     2003  
     (Dollars in Thousands)  

Net income, as reported

   $ 13,728     $ 13,101     $ 12,010  

Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects

     (268 )     (59 )     (70 )
                        

Pro forma net income

   $ 13,460     $ 13,042     $ 11,940  
                        

Earnings per share:

      

Basic - as reported

   $ 1.15     $ 1.12     $ 1.03  
                        

Basic - pro forma

   $ 1.13     $ 1.11     $ 1.02  
                        

Diluted - as reported

   $ 1.14     $ 1.11     $ 1.02  
                        

Diluted – pro forma

   $ 1.12     $ 1.10     $ 1.01  
                        

In December 2005, the Company decided to accelerate the vesting of 7,332 options to purchase its common stock to avoid the income statement impact of adopting FASB Statement 123R in future years.

This excerpt taken from the ABCB 10-Q filed May 9, 2005.

Note 6. Stock-Based Compensation

 

At March 31, 2005, the Company has a stock-based employee compensation plan. The Company accounts for this plan under the recognition and measurement principles of APB Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations. No stock-based employee compensation cost is reflected in net income (except for compensation cost associated with restricted shares), as all options granted under this plan had an exercise price equal to the market value of the underlying stock on the date of grant. The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of FASB Statement No. 123, Accounting for Stock-Based Compensation, to stock-based employee compensation.

 

     For The Three Months
Ended March 31,


 
     2005

    2004

 
     (Dollars in Thousands)  

Net income, as reported

   $ 3,600     $ 3,186  

Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects

     (15 )     (20 )
    


 


Pro forma net income

   $ 3,585     $ 3,166  
    


 


Earnings per share:

                

Basic - as reported

   $ 0.31     $ 0.27  
    


 


Basic - pro forma

   $ 0.30     $ 0.27  
    


 


Diluted - as reported

   $ 0.30     $ 0.27  
    


 


Diluted - pro forma

   $ 0.30     $ 0.27  
    


 


 

10


Table of Contents
This excerpt taken from the ABCB 10-K filed Mar 16, 2005.

Stock-Based Compensation

 

Statement of Financial Accounting Standards (SFAS) No. 123, Accounting for Stock-Based Compensation, encourages all entities to adopt a fair value based method of accounting for employee stock compensation plans whereby compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period. However, it also allows an entity to continue to measure compensation cost for those plans using the intrinsic value based method of accounting prescribed by Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees, whereby compensation cost is the excess, if any, of the quoted market price of the stock at the grant date over the amount an employee must pay to acquire the stock. The Company has elected to continue with the accounting methodology of Opinion No. 25. No stock-based employee compensation cost is reflected in net income, as all options granted under the plans had an exercise price equal to the market value of the underlying stock on the date of grant.

 

The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of FASB Statement No. 123 to stock-based employee compensation.

 

     Years Ended December 31,

 
     2004

    2003

    2002

 
     (Dollars in Thousands)  

Net income, as reported

   $ 13,101     $ 12,010     $ 10,355  

Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects

     (59 )     (70 )     (54 )
    


 


 


Pro forma net income

   $ 13,042     $ 11,940     $ 10,301  
    


 


 


Earnings per share:

                        

Basic - as reported

   $ 1.12     $ 1.03     $ 0.87  
    


 


 


Basic - pro forma

   $ 1.11     $ 1.02     $ 0.86  
    


 


 


Diluted - as reported

   $ 1.11     $ 1.02     $ 0.87  
    


 


 


Diluted - pro forma

   $ 1.10     $ 1.01     $ 0.86  
    


 


 


 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki